Answer:
(Haloperidol decanoate is a depot medication, given intramuscularly every 2 to 4 weeks. It is unknown whether the patient has a support system. The patient probably received education, including written instructions prior to discharge. Changing to another classification of medication would not necessarily improve compliance.)
Explanation:
Answer:
A
Explanation:
Based on the information provided in this scenario it can be said that this advertisement would raise concern since the supplement has not been evaluated by the FDA, it might not be safe. The Food and Drug Administration (FDA) is in charge of making sure that products are 100% safe for the end consumer before a product hits store shelves. A product such as the one being advertise may actually be harmful since it has not yet been approved by the FDA. Also advertisement companies' goals are to make people aware of the product and convince them to buy it, therefore they can twist and spin actual facts in order to accomplish those goals.
